Budhesh Dhamija

Budhesh Dhamija has extensive work experience in the field of clinical regulatory affairs. Budhesh is currently employed at ITM Isotope Technologies Munich SE, where they hold the position of Senior Director in Clinical Regulatory Affairs. Prior to this role, they worked as a Director and Team Leader in the same field at ITM Isotope Technologies Munich SE.

Before joining ITM Isotope Technologies Munich SE, Budhesh worked at CSL Behring as a Senior Manager in Regulatory Intelligence and Policy, and also as a Regulatory Regional Manager for the European Union. Budhesh has also worked at Novo Nordisk, where they held various roles such as Senior Regulatory Affairs Professional, Senior Safety Surveillance Medical Writer, and Safety Medical Writer/Advisor.

Additionally, Budhesh has experience working as a Medical Writing Consultant for Novo Nordisk at S-Cubed. Budhesh has also worked as a Team Lead in Medical Writing at APCER PHARMA and as a Medical Writer at Cognizant Technology Solutions. Budhesh began their career at Kinapse, where they worked as a Medical Writer, handling regulatory writing, protocol development, literature search, and presentation development.

Budhesh started their professional journey at LUPIN LIMITED as a Senior Training Officer. Overall, Budhesh Dhamija's work experience highlights their expertise in clinical regulatory affairs, regulatory writing, and medical writing.

Budhesh Dhamija has a Masters in Pharmacy with a focus on Pharmaceutical Marketing from Manipal Academy of Higher Education, which they completed from 2004 to 2006. Budhesh also obtained a Post Graduate Degree in Advanced Clinical Research from the Institute of Clinical Research (India), specializing in Clinical Research and Medical Writing, from 2007 to 2008. Prior to that, Budhesh completed their Bachelors in Pharmacy from Delhi University from 2000 to 2004. In addition, they are a certified RAPS Member from the Regulatory Affairs Certification Program, which they obtained in March 2021.